Abstract:Drug repositioning identifies novel therapeutic potentials for existing drugs and is considered an attractive approach due to the opportunity for reduced development timelines and overall costs. Prior computational methods usually learned a drug's representation from an entire graph of drug-disease associations. Therefore, the representation of learned drugs representation are static and agnostic to various diseases. However, for different diseases, a drug's mechanism of actions (MoAs) are different. The relevant context information should be differentiated for the same drug to target different diseases. Computational methods are thus required to learn different representations corresponding to different drug-disease associations for the given drug. In view of this, we propose an end-to-end partner-specific drug repositioning approach based on graph convolutional network, named PSGCN. PSGCN firstly extracts specific context information around drug-disease pairs from an entire graph of drug-disease associations. Then, it implements a graph convolutional network on the extracted graph to learn partner-specific graph representation. As the different layers of graph convolutional network contribute differently to the representation of the partner-specific graph, we design a layer self-attention mechanism to capture multi-scale layer information. Finally, PSGCN utilizes sortpool strategy to obtain the partner-specific graph embedding and formulates a drug-disease association prediction as a graph classification task. A fully-connected module is established to classify the partner-specific graph representations. The experiments on three benchmark datasets prove that the representation learning of partner-specific graph can lead to superior performances over state-of-the-art methods. In particular, case studies on small cell lung cancer and breast carcinoma confirmed that PSGCN is able to retrieve more actual drug-disease associations in the top prediction results. Moreover, in comparison with other static approaches, PSGCN can partly distinguish the different disease context information for the given drug.

Graph Neural Network-Based Modeling with Subcategory Exploration for Drug Repositioning

Multi-Label Classification with Dual Tail-Node Augmentation for Drug Repositioning.

Drug repositioning with adaptive graph convolutional networks

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Drug repositioning based on weighted local information augmented graph neural network

Drug Repositioning Method Based on Deep Neural Network

Enhancing Drug Repositioning through Local Interactive Learning with Bilinear Attention Networks

Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network

Boosting drug-disease association prediction for drug repositioning via dual-feature extraction and cross-dual-domain decoding

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

A weighted bilinear neural collaborative filtering approach for drug repositioning

Deep learning of multimodal networks with topological regularization for drug repositioning

Empowering Graph Neural Network-Based Computational Drug Repositioning with Large Language Model-Inferred Knowledge Representation

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

deepDR: a network-based deep learning approach to in silico drug repositioning

SADR: Self-supervised Graph Learning with Adaptive Denoising for Drug Repositioning

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning